Brief: Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock
06/01/2026 23:16
Jan 7 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O: ARROWHEAD PHARMACEUTICALS ANNOUNCES PROPOSED OFFERINGS OF CONVERTIBLE SENIOR NOTES AND COMMON STOCK ARROWHEAD PHARMACEUTICALS - ANNOUNCES $500 MILLION CONVERTIBLE SENIOR NOTES OFFERING DUE 2032 ARROWHEAD PHARMACEUTICALS - ANNOUNCES $200 MILLION COMMON STOCK OFFERING Source text: ID:nBw238Klga Further company coverage: ARWR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arrowhead Pharmaceuticals
See all newsBrief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers